| RS1554504678 |
RHOBTB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Developmental and epileptic encephalopathy |
| RS1554504681 |
RHOBTB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Rett syndrome, Developmental and epileptic encephalopathy |
| RS1554504684 |
RHOBTB2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 64 |
| RS1554505381 |
KMT2C
|
Health Risk |
Pathogenic |
Kleefstra syndrome 2, KMT2C-related NDD |
| RS1554508985 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiac arrhythmia, ankyrin-B-related |
| RS1554510884 |
DDHD2
|
Health Risk |
Pathogenic |
— |
| RS1554511216 |
DDHD2
|
Health Risk |
Likely pathogenic |
— |
| RS1554512658 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1554512816 |
KRIT1
|
Health Risk |
Likely pathogenic |
— |
| RS1554513061 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1554513070 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1554513911 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1554514380 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, KRIT1-related disorder |
| RS1554514507 |
CHRNA2
|
Health Risk |
Pathogenic |
Autosomal dominant nocturnal frontal lobe epilepsy 4, Autosomal dominant nocturnal frontal lobe epilepsy 4 |
| RS1554515767 |
DDHD2
|
Health Risk |
Likely pathogenic |
— |
| RS1554517327 |
ERLIN2
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic paraplegia, Spastic paraplegia 18a |
| RS1554517382 |
ERLIN2
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 18, Hereditary spastic paraplegia 18 |
| RS1554517725 |
LPL
|
Health Risk |
Likely pathogenic |
Hyperlipoproteinemia, type I |
| RS1554518369 |
KRIT1
|
Health Risk |
Likely pathogenic |
— |
| RS1554518386 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1554518541 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1554518750 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1554518783 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1554518790 |
KRIT1
|
Health Risk |
Likely pathogenic |
Cavernous hemangioma, Cavernous hemangioma |
| RS1554519254 |
WRN
|
Health Risk |
Pathogenic |
Werner syndrome, Werner syndrome |
| RS1554519422 |
RP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 1, Leber congenital amaurosis 1 |
| RS1554519449 |
WRN
|
Health Risk |
Likely pathogenic |
Werner syndrome, Werner syndrome |
| RS1554519459 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS1554519462 |
ADAM22
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 61 |
| RS1554519518 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS1554519533 |
RP1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1554519538 |
RP1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1554519546 |
RP1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1554519554 |
RP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 1 |
| RS1554519555 |
RP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS1554519577 |
RP1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1554519635 |
RP1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS1554519651 |
RP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS1554519662 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS1554519798 |
CUX1
|
Health Risk |
Likely pathogenic |
Global developmental delay with or without impaired intellectual development, Global developmental delay with or without impaired intellectual development |
| RS1554519822 |
RP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 1 |
| RS1554520068 |
RP1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1554520924 |
SLC39A14
|
Health Risk |
Pathogenic |
Hyperostosis cranialis interna, Hyperostosis cranialis interna |
| RS1554522035 |
ANK1
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS1554523224 |
TPK1
|
Health Risk |
Likely pathogenic |
Childhood encephalopathy due to thiamine pyrophosphokinase deficiency, Childhood encephalopathy due to thiamine pyrophosphokinase deficiency |
| RS1554523526 |
TTPA
|
Health Risk |
Pathogenic |
— |
| RS1554523565 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1554524061 |
TTPA
|
Health Risk |
Pathogenic |
Familial isolated deficiency of vitamin E, Familial isolated deficiency of vitamin E |
| RS1554524697 |
CYP7B1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia, Hereditary spastic paraplegia |
| RS1554525125 |
TTPA
|
Health Risk |
Pathogenic |
Familial isolated deficiency of vitamin E, Familial isolated deficiency of vitamin E |
| RS1554525128 |
TTPA
|
Health Risk |
Pathogenic |
Familial isolated deficiency of vitamin E, Familial isolated deficiency of vitamin E |
| RS1554526454 |
HGSNAT
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS1554526666 |
KMT2C
|
Health Risk |
Likely pathogenic |
— |
| RS1554526707 |
WRN
|
Health Risk |
Pathogenic |
Werner syndrome, Werner syndrome |
| RS1554527032 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1554527169 |
KRIT1
|
Health Risk |
Pathogenic |
Cavernous hemangioma, Cerebral cavernous malformation |
| RS1554527775 |
WRN
|
Health Risk |
Pathogenic |
Werner syndrome, Werner syndrome |
| RS1554527779 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1554527817 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1554527919 |
KRIT1
|
Health Risk |
Likely pathogenic |
— |
| RS1554527922 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1554527925 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1554528411 |
WRN
|
Health Risk |
Pathogenic |
Werner syndrome, Werner syndrome |
| RS1554528541 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1554528662 |
KRIT1
|
Health Risk |
Pathogenic |
— |
| RS1554529341 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1554530901 |
WRN
|
Health Risk |
Pathogenic |
— |
| RS1554531744 |
HGSNAT
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS1554532283 |
HGSNAT
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS1554533006 |
WRN
|
Health Risk |
Likely pathogenic |
Werner syndrome, Werner syndrome |
| RS1554533211 |
HGSNAT
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS1554537586 |
HGSNAT
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS1554537612 |
HGSNAT
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS1554537613 |
HGSNAT
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS1554537807 |
HGSNAT
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS1554537841 |
HGSNAT
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS1554537963 |
BPNT2
|
Health Risk |
Likely pathogenic |
— |
| RS1554539120 |
KRIT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1554541834 |
EYA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Melnick-Fraser syndrome, Melnick-Fraser syndrome |
| RS1554542073 |
EYA1
|
Health Risk |
Pathogenic |
— |
| RS1554543126 |
ANK1
|
Health Risk |
Likely pathogenic |
— |
| RS1554544827 |
SYNE1
|
Health Risk |
Pathogenic |
— |
| RS1554544862 |
ANK1
|
Health Risk |
Pathogenic |
— |
| RS1554545462 |
ATP6V1B2
|
Health Risk |
Likely pathogenic |
— |
| RS1554546372 |
SLC20A2
|
Health Risk |
Likely pathogenic |
— |
| RS1554546830 |
SLC20A2
|
Health Risk |
Pathogenic |
Idiopathic basal ganglia calcification 1, Idiopathic basal ganglia calcification 1 |
| RS1554547400 |
FGFR1
|
Health Risk |
Pathogenic |
— |
| RS1554547986 |
GDAP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 4A, Charcot-Marie-Tooth disease |
| RS1554548102 |
FGFR1
|
Health Risk |
Likely pathogenic |
— |
| RS1554548253 |
FGFR1
|
Health Risk |
Pathogenic |
Hartsfield-Bixler-Demyer syndrome, Hartsfield-Bixler-Demyer syndrome |
| RS1554548334 |
GDAP1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4A, Charcot-Marie-Tooth disease type 4A |
| RS1554548434 |
FGFR1
|
Health Risk |
Likely pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Pfeiffer syndrome |
| RS1554548840 |
EYA1
|
Health Risk |
Pathogenic |
Melnick-Fraser syndrome, Melnick-Fraser syndrome |
| RS1554549291 |
FKBP6
|
Health Risk |
Pathogenic |
Spermatogenic failure 77, Male infertility |
| RS1554549628 |
FGFR1
|
Health Risk |
Pathogenic |
— |
| RS1554550339 |
SYNE1
|
Health Risk |
Pathogenic |
— |
| RS1554550637 |
EYA1
|
Health Risk |
Pathogenic |
Rare genetic deafness, Rare genetic deafness |
| RS1554551657 |
FGFR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hartsfield-Bixler-Demyer syndrome, Hartsfield-Bixler-Demyer syndrome |
| RS1554551667 |
FGFR1
|
Health Risk |
Pathogenic |
Hartsfield-Bixler-Demyer syndrome, Hartsfield-Bixler-Demyer syndrome |
| RS1554551706 |
FGFR1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Pfeiffer syndrome |